About Amanta Healthcare Limited - Mainboard IPO
Amanta Healthcare Limited is a pharmaceutical company based in Ahmedabad, India, specializing in the development, manufacturing, and marketing of sterile liquid products. Incorporated in December 1994, the company focuses on producing large-volume parenterals (LVPs) and small-volume parenterals (SVPs) using advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. The company operates a state-of-the-art manufacturing facility in Hariyala, Gujarat, serving critical therapeutic segments including IV fluids, diluents, ophthalmic solutions, respiratory care, and irrigation solutions. The company also manufactures medical devices like irrigation solutions, first-aid products, and eye lubricants.
READ DRHP HERE: SEBI|DRHP|AMANTA LTD|
IPO Details
| Key Points | Information |
|---|---|
| IPO Price Band | ā¹120 ā ā¹126 per share |
| Minimum Lot Size | 119 shares (about ā¹14,994 at highest price) |
| Issue Size | ā¹126 crore (100% fresh issue) |
| Face Value | ā¹10 per share |
| Stock Exchanges | BSE and NSE (NSE Mainboard IPO, BSE Mainboard IPO) |
| Registrar | MUFG Intime India Private Limited click here |
| Book-running Managers | Beeline Capital Advisors Private Limited |
| Offer Structure | QIB - up to 50%, Retail - up to 35%, NII - up to 15% |
IPO Timeline (Important Dates)
| Event | Date |
|---|---|
| IPO Opens | 1st September 2025 |
| IPO Closes | 3rd September 2025 |
| Allotment Date | 4th September 2025 |
| Refunds/Unsuccessful Bids | 5th September 2025 |
| Shares in Demat Account | 5th September 2025 |
| Listing Date | 9th September 2025 |
What Is the Money Used For?
- Funding capital expenditure for civil construction work and purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat.
- Funding capital expenditure for purchase of equipment, plant and machinery for setting up new manufacturing line for Small Volume Parenteral (SVP) at Hariyala, Kheda, Gujarat.
- General corporate purposes.
Key Financials: (FY23-FY25)
| Financial Metric | FY23 (ā¹ Cr) | FY24 (ā¹ Cr) | FY25 (ā¹ Cr) |
|---|---|---|---|
| Revenue | 259 | 280 | 275 |
| Profit After Tax (PAT) | -2.11 | 3.63 | 10.5 |
| EBITDA (Profit from Operations) | 56.3 | 58.8 | 61.1 |
| EBITDA Margin | 21.4% | 20.9% | 22.1% |
| PAT Margin | -0.8% | 1.3% | 3.8% |
| Return on Equity (ROE) | -3.3% | 5.3% | 12.4% |
| ROCE | 12.2% | 12.8% | 13.7% |
| Earnings Per Share (EPS) | ā¹3.71 (FY25 Basic) | ||
| Debt to Equity | 2.02 |
- Revenue: Total sales made from business
- EBITDA: Profits before interest, taxes, and certain costs
- PAT (Profit After Tax): Final profit after all expenses
- ROE/ROCE: How well the company uses investor money
- EPS: Profit for each share.
Analysis
- The companyās revenue has remained relatively stable around ā¹275-280 crores over the past three years
- Profits have shown remarkable improvement - from a loss of ā¹2.11 crore in FY23 to profit of ā¹10.5 crore in FY25
- EBITDA margins have consistently remained healthy in the 20-22% range, showing good operational efficiency
- The company has achieved a financial turnaround with significant improvement in profitability metrics
Why Some Investors Like This Mainboard IPO
- The company is a specialist in sterile liquid pharmaceutical products with advanced BFS technology
- Manufacturing facility is strategically located in Gujarat with WHO-GMP compliance
- Good growth in profits and operational efficiency in recent years
- Strong presence in both domestic (320+ distributors) and international markets (exports to 21 countries)
- Mainboard IPO status: Listed on both BSE and NSE for better access
Points That Need Caution
- The company has a high debt-to-equity ratio of 2.02, indicating significant reliance on debt
- Revenue growth has been stagnant over the past three years
- PAT margin of 3.8% remains modest despite improvement
- The business depends on raw material costs and regulatory changes in pharmaceutical sector
- Single manufacturing facility creates operational concentration risk.
Industry Position
Amanta Healthcare operates in the growing IV fluids segment alongside established players like Baxter India, Fresenius Kabi India, B. Braun Medical, and other domestic companies. The Indian IV fluids market is valued at ā¹171.44 billion in 2024 and expected to grow at 8.3% CAGR to reach ā¹380.54 billion by 2034.
IPO FAQS
What is an IPO?
- An IPO (Initial Public Offering) is when a private company sells its shares to the public for the first time to raise money.
- Example: If a well-known pizza company wants to grow, it can list its shares on the stock exchange so anyone can buy a piece of the company.
How can you apply for an IPO (using Zerodha or Upstox)?
- Make sure you have a Demat account and your bank account is linked.
- Steps:
- Log in to your brokerās app (e.g., Zerodha Kite, Upstox).
- Go to the IPO section.
- Select the companyās IPO you want to apply for.
- Enter how many shares (or ālotsā) you want and the price you wish to bid.
- Enter your UPI ID, submit your application, and approve the UPI payment request.
How are IPO shares allotted?
- If more people want shares than are available, the company uses a lottery system to decide who gets them.
- If you donāt get shares, your money is simply returned.
What is GMP (Grey Market Premium)?
- GMP shows the extra price people are willing to pay for IPO shares before they officially start trading.
- Example: If IPO price is ā¹100 and GMP is ā¹20, people are unofficially ready to pay ā¹120. It hints at the IPOās popularity but isnāt a guarantee.
Where to check upcoming IPOs (IPO calendar)?
- Visit popular finance sites like Chittorgarh, IPOWatch, or official exchange websites (NSE, BSE) and look for the āUpcoming IPOā section.
What are IPO listing gains?
- If the shareās price rises on the first trading day, you can make instant profit.
- Example: You buy at ā¹150, and it opens at ā¹200, you gain ā¹50 per share.
How can you make profit from an IPO?
- Quick gains on listing day (if the stock price goes up).
- Long-term: If the company grows, the share price could increase further.
Which IPO is best to buy?
- There is no single best IPO. Check the companyās background, current demand, and GMP, but always research before investing.
- High GMP or popularity doesnāt guarantee profits.
Are IPOs safe?
- IPOs can be profitable but also risky; prices can go up or down sharply.
- Only invest if you are ready for potential losses.
How to check IPO allotment status?
- After the IPO process, check on exchanges (BSE/NSE websites) or the IPO registrarās site (like K-Fintech, Bigshare,or mufg-intime) by entering your PAN or application number to see if you got shares.
Important Tips for Retail Investors Applying for an IPO
- Use Only Your Own PAN Card:
Avoid using the same PAN card for multiple IPO applications. For example, if you have already applied using your PAN for one IPO, donāt try to apply again with the same PAN under different accounts or through others. - Apply in the Right Category:
Ensure you select the correct investor category (such as Retail Individual Investor) when filling out your application. Applying under a wrong category can lead to rejection or disqualification. - Maintain Sufficient Bank Balance:
Before applying, ensure your bank account linked to the application has enough funds to cover the full bid amount. For instance, if the IPO application requires a payment of ā¹15000, make sure your account holds at least that amount. - Use Your Own Bank Account:
Always apply through your own bank account. Using someone elseās account can cause your application to be rejected during the verification process. - Avoid Last-Minute Applications:
Donāt wait until the deadline day or moments before to apply. Last-minute submissions may face technical glitches or processing delays, reducing the chances of success.